Study wrapper · #690
Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.
Editor's note
This study complements the group's transcriptomic work by looking at protein-level changes: in a rat stroke model 24 hours after occlusion, Semax was associated with upregulated active CREB (a recovery-linked factor) in subcortical tissue and downregulated MMP-9, c-Fos and active JNK (linked to inflammation and cell death) in adjacent cortex. Moving from mRNA to protein strengthens internal consistency of the proposed neuroprotective mechanism. Still, it is preclinical, single-model, single-lab work with molecular endpoints and no behavioral or clinical outcome. Read it as mechanistic corroboration rather than efficacy evidence. These are preclinical findings; human data are needed before clinical conclusions can be drawn.
Plain-language abstract
Earlier work showed Semax changes gene activity after a stroke; this rat study checked whether those changes show up at the protein level, which is closer to real cellular action. One day after a temporary stroke, the researchers measured several key proteins. In animals given Semax, a recovery-associated protein (active CREB) went up in the deep injured region, while proteins tied to inflammation and cell death (MMP-9, c-Fos and active JNK) went down in the neighboring cortex. The authors argue this combination, less inflammation and cell death plus more recovery signaling, helps explain how Semax protects brain tissue. This is laboratory work in rats measuring molecules, not a test of Semax as a stroke treatment in people, and it reports no clinical outcomes.